|
TBRG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.273000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.476620E-01 |
| Normal-vs-Stage2 |
1.483790E-01 |
| Normal-vs-Stage3 |
6.879800E-01 |
| Normal-vs-Stage4 |
6.518200E-01 |
| Stage1-vs-Stage2 |
4.217600E-01 |
| Stage1-vs-Stage3 |
4.350800E-01 |
| Stage1-vs-Stage4 |
1.414020E-01 |
| Stage2-vs-Stage3 |
2.199800E-01 |
| Stage2-vs-Stage4 |
1.008600E-01 |
| Stage3-vs-Stage4 |
4.711600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.302800E-01 |
| Normal-vs-AfricanAmerican |
1.113840E-01 |
| Normal-vs-Asian |
6.181500E-02 |
| Caucasian-vs-AfricanAmerican |
2.667200E-01 |
| Caucasian-vs-Asian |
8.663500E-02 |
| AfricanAmerican-vs-Asian |
1.806780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.392400E-01 |
| Normal-vs-Female |
1.249990E-02 |
| Male-vs-Female |
1.508100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.186400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.530200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.443800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.380600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.208200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.369600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.642800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.340000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.948000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.562000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.433860E-02 |
| Normal-vs-Grade 2 |
4.219900E-02 |
| Normal-vs-Grade 3 |
8.723800E-01 |
| Normal-vs-Grade 4 |
2.827400E-01 |
| Grade 1-vs-Grade 2 |
1.062210E-01 |
| Grade 1-vs-Grade 3 |
8.276100E-03 |
| Grade 1-vs-Grade 4 |
4.435000E-03 |
| Grade 2-vs-Grade 3 |
5.896300E-02 |
| Grade 2-vs-Grade 4 |
1.829750E-02 |
| Grade 3-vs-Grade 4 |
2.183000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.455500E-02 |
| Normal-vs-ccB subtype |
5.368800E-01 |
| ccA subtype-vs-ccB subtype |
1.909780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.010640E-01 |
| Normal-vs-N1 |
4.799800E-01 |
| N0-vs-N1 |
1.993190E-01 |
|
|
